Ananda Pharma Confirms Safety of CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market. Today (June 17), Ananda published the full clinical study report from its Phase I pharmacokinetic trial of its proprietary MRX1 compound, confirming all objectives were met, a clean [...]